Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENALIDOMIDE vs LERCANIDIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENALIDOMIDE vs LERCANIDIPINE: Safety Overview

Metric LENALIDOMIDE LERCANIDIPINE
Total FAERS Reports 349,955 3,767
Deaths Reported 35,942 248
Death Rate 10.3% 6.6%
Hospitalizations 86,495 2,249
Average Patient Age 69.9 yrs 65.8 yrs
% Female Patients 50.0% 47.8%
FDA Approval Date Aug 3, 2023 N/A
Manufacturer Padagis US LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A